Navigation Links
Hoya Announces Second Quarter and First Half Financial Results for FY2008
Date:11/10/2008

TOKYO, November 10 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the second quarter ended September 30, 2008. Net sales were 128.3 billion yen for the quarter, representing an increase of 27.1% from 100.9 billion yen in the second quarter of 2007 mainly reflecting the additional results of PENTAX included in the scope of consolidation during the previous fiscal year.

Operating income was 20.6 billion yen, a 23.2% decrease compared with 26.8 billion yen in the second quarter of 2007, due mainly to order decrease and the drop in the product price in global economic downturn. Net income for the second quarter was 19.1 billion yen, a 9.0% decrease compared with 21.0 billion yen in the same period of 2007. Earnings per share for the quarter were 44.21 yen compared with 48.64 yen in the second quarter of 2007.

For the first six months ending September 30, 2008, net sales were 258.5 billion yen, a 30.1% growth compared with 198.7 billion yen in the same period of 2007. Operating income was 42.4 billion yen, a 14.2% decrease compared with 49.4 billion yen in the first half of 2007, while net income was 40.3 billion yen, a 5.8% increase compared with 38.1 billion yen in the same period of 2007. Earnings per share were 93.18 yen compared with 88.25 yen in the first half of 2007.

"Shrinkage of the semiconductor market and severe price competition in overall business fields continues to have a negative impact on our second quarter 2008," said Hiroshi Hamada, chief operating officer of HOYA. "The market will continue to be weak, however, we will promote expansion of our growth areas including eyeglass business, endoscopic system and contact lens retail business."

The full quarterly report is available in "Financial Statement" page in HOYA website Investor Relations section at: http://www.hoya.co.jp/english/

*Results are preliminary and unaudited.

*The yen amounts shown therein are rounded down to the nearest 100 million.

About Hoya Corporation

Hoya Corporation is a global technology company based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. Hoya is active in four fields of business: Information Technology makes mask blanks and photomasks for the semiconductor devices and LCD panels, optical lenses for digital cameras, and glass memory disks for HDDs. The Eye Care provides eyeglasses, operates retail shops for contact lenses, and makes intraocular lenses for cataract surgery. The Life Care provides endoscopic system. The Imaging produces SLR/compact digital cameras, interchangeable lenses, lens modules and microlenses. Hoya now has over 100 subsidiaries and affiliates, and employs approximately 38,000 people worldwide.

Contact Information:

Akiko Maeyama / Naoji Ito

Corporate Communications

Hoya Group

Tel: +81-3-3232-0065

E-mail: HOYA-pr@mb.hoya.co.jp


'/>"/>
SOURCE Hoya Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. WaferGen Announces Third Quarter 2008 Financial Results
2. ScienceBased Health Announces the Launch of Diavis(TM), a New Dietary Supplement for the 81 Million Americans With or at Risk for Diabetes
3. Health Robotics Announces Strategic Partnership in Japan for its CytoCare(TM) Robot with TOSHO Inc.
4. WellSpring Pharmaceutical Corp. Announces Hire of Wayne Miller as Vice President, Sales & Marketing, Consumer Brands
5. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
6. BIO-key(R) Announces Third Quarter 2008 Earnings Release and Conference Call Schedule
7. BioMS Medical Announces Third Quarter 2008 Results
8. Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
9. deCODE genetics Announces Third Quarter 2008 Financial Results
10. Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
11. Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)...  Only nine percent of U.S. consumers believe pharmaceutical ... 16 percent believe health insurance companies do, according to ... of U.S. adults believe health care providers (such as ... hospitals (23%). "We are in the midst ... , vice president of reputation management and public affairs ...
(Date:1/17/2017)... ... January 17, 2017 , ... One Million Solutions ... (SafeTEC™), $3 million in investment towards 15+ TEC Validation Projects™. As a pre-competitive ... their applicability in drug safety assessment, for the industry as a whole. , ...
(Date:1/17/2017)... COLUMBUS, Ohio , Jan. 17, 2017  On ... with the 35th Annual J.P. Morgan Healthcare Conference in ... Joseph D. Kittle, Jr. , spoke to pharmaceutical ... technology developed by ProclaRx to break down and destroy ... which protect bacteria and prevent antibiotics and the body,s ...
(Date:1/16/2017)... 16, 2017  Eurofins Genomics today announced the expansion ... customers to receive their primers in a shorter turnaround ... quality found with other providers. Express oligos are available ... at no additional fee. Researchers use ... including DNA sequencing, genotyping, site-directed mutagenesis, and cloning. Often, ...
Breaking Biology Technology:
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
(Date:12/8/2016)... PUNE, India , Dec. 8, 2016 Market Research ... and Service Market. The global Mobile Biometric Security and Service Market ... period 2016 to 2022. Market Highlights: ... , , ... fast pace due to the increasing need of authentication and security ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , ... expansion of its patent portfolio, which grew to over 40 granted and ... , , ... recently filed patent entitled " System, Device, and Method Estimating ... that enables device makers to forego costly hardware components needed to estimate ...
Breaking Biology News(10 mins):